At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Clarithromycin +2 moredrug
Likely dose
Clarithromycin 500mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clarithromycin as Adjuvant to Periodontal Debridement in the Treatment of Generalized Aggressive Periodontitis: Randomized Clinical Trial
Universidade Estadual Paulista Júlio de Mesquita Filho·interventional·Posted Jul 12, 2016·Updated Nov 21, 2017
In Brief
A clinical study evaluating Clarithromycin, Placebo, and 1 other intervention for Aggressive Periodontitis. Completed, enrolled 40 participants.
Detailed Summary
To assess the periodontal clinical response and the possible adverse effects of the clarithromycin combined to periodontal mechanical therapy in the treatment of patients with generalized aggressive periodontitis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAggressive Periodontitis
Countries--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartMar 2014
Primary CompletionAug 2015
Study CompletionNov 2015
First PostedJul 2016
TodayJul 2026
First PostedJul 12, 2016
Enrollment StartMar 1, 2014
Primary CompletionAug 1, 2015
Study CompletionNov 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 10.0 years ago
Interventions
Clarithromycindrug
Use of 500mg of Clarithromycin twice a day for 3 days
Placebodrug
Use of placebo tablets twice a day for 3 days.
One-stage full-mouth ultrasonic debridement (FMUD)other
One session of Periodontal debridement using ultrasonic device.